Physician profile
Michael Rothkopf
NPI 1689673576
$7,066.13
in general payments reported to CMS, 2019-2025
43 companies · $1,164 in 2025
The $1,164 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $999 · 2020: $363 · 2021: $600 · 2022: $1,165 · 2023: $1,423 · 2024: $1,351 · 2025: $1,164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,939.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,938.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $896.80 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $732.66 | 2021-2025 | Verquvo, Capvaxive |
| Astrazeneca Pharmaceuticals Lp | $717.89 | 2019-2025 | Farxiga, Lokelma |
| E.R. Squibb & Sons, L.L.C. | $548.28 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $496.73 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $412.38 | 2020-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $397.72 | 2019-2025 | Jardiance |
| Philips North America LLC | $303.67 | 2020-2025 | (Ck4) Mcot, (Ck7) Extended Holter, Extended Holter |
| Janssen Pharmaceuticals, INC | $269.83 | 2019-2024 | Xarelto |
| Amgen INC. | $219.37 | 2019-2025 | Repatha, Repatha |
| Sanofi-Aventis U.S. LLC | $202.86 | 2019-2024 | |
| Novo Nordisk INC | $200.88 | 2019-2024 | Ozempic, Rybelsus |
| Cvrx, INC. | $199.22 | 2024 | Barostim Neo System |
| Abbott Laboratories | $190.60 | 2022-2024 | Cardiomems |
| Amarin Pharma, INC. | $174.53 | 2019-2022 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $118.51 | 2023-2025 | Bodyguardian |
| Vifor Pharma, INC. | $105.38 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $73.46 | 2023-2024 | Inpefa |
| Kiniksa Pharmaceuticals International, Plc | $68.28 | 2024 | Arcalyst |
| Baxter Healthcare | $66.48 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Heartflow, INC. | $65.64 | 2022 | |
| Inspire Medical Systems, INC. | $64.58 | 2023-2024 | Inspire |
| Scpharmaceuticals INC. | $63.31 | 2023-2025 | |
| Esperion Therapeutics, INC. | $54.01 | 2022-2023 | Nexletol |
| Chiesi USA, INC. | $36.95 | 2021 | |
| Kiniksa Pharmaceuticals, Ltd. | $35.88 | 2021-2023 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $34.76 | 2021 | |
| Astellas Pharma US INC | $34.36 | 2019 | |
| Edwards Lifesciences Corporation | $29.14 | 2019-2022 | |
| Bardy Diagnostics, INC. | $25.00 | 2019 | |
| Alnylam Pharmaceuticals INC. | $24.99 | 2019 | |
| Arbor Pharmaceuticals, INC. | $24.87 | 2021 | |
| Atricure, INC. | $21.65 | 2023 | |
| Koya Medical, INC. | $20.22 | 2025 | Koya Medical, Dayspring |
| Irhythm Technologies, INC. | $19.26 | 2020 | |
| Tactile Systems Technology INC | $18.99 | 2023 | Flexitouch Plus, Entre Plus |
| Recor Medical INC | $16.08 | 2025 | Paradise Ultrasound Renal Denervation System |
| Cleerly, INC. | $15.74 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Gilead Sciences, INC. | $15.73 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $13.01 | 2019 | |
| G Medical Diagnostic Services, INC. | $12.74 | 2022 | |
| Medtronic Vascular, INC. | $11.94 | 2019 | |
| Portola Pharmaceuticals, LLC | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Rothkopf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.